PRMEbenzinga

HC Wainwright & Co. Initiates Coverage On Prime Medicine with Buy Rating, Announces Price Target of $10

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 20, 2024 by benzinga

    HC Wainwright & Co. Initiates Coverage On Prime Medicine with Buy Rating, Announces Price Target of $10 | PRME Stock News | Candlesense